08/05/2026
Join two experienced clinicians for an in-depth conversation, including a TalisMann™ case review, clinical insights, and practical tips you can apply in your practice.
In this webinar, you’ll also learn how other clinicians treat chronic pain with Bioventus’ peripheral nerve stimulation (PNS) systems.
Wednesday, August 19 8 PM (ET)
Register today to reserve your spot:
https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=NnTjHz5FuEmJGaUybARhfOACayPdSTZOgzVVijqyQzVUNVdKUFFWSlkyRUIwN0RON01TVlc0R0kyNSQlQCN0PWcu&origin=QRCode
-----------------------------
Individual results may vary.
Indications for Use for TalisMann: The TalisMann Neuromodulation System is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as an adjunct to other modes of therapy (e.g., medications). The TalisMann Neuromodulation System is not intended to treat pain in the craniofacial region.
Contraindications: Do not use TalisMann in users who have an implanted demand cardiac pacemaker, implanted cardioverter defibrillator (ICD), or other implanted active device, or who have bleeding disorders that cannot be stopped in advance of the implantation procedure. Do not use the system where a metallic implant or a cancerous lesion is present in the immediate implant area. Effects of stimulation during pregnancy are not known. TalisMann is capable of producing skin irritation and muscle ache in the area of stimulation.
Full prescribing information can be found in the Clinician Guide or BioventusPNS.com/TalisMann_IFU